WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹422 Cr | ₹-718 Cr | ₹-1,521 Cr | ₹-762 Cr | ₹-840 Cr |
What is the latest Net Current Assets ratio of WOCKHARDT ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹422 Cr |
| Mar2024 | ₹-718 Cr |
| Mar2023 | ₹-1,521 Cr |
| Mar2022 | ₹-762 Cr |
| Mar2021 | ₹-840 Cr |
How is Net Current Assets of WOCKHARDT Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹422 Cr | Positive | |
| Mar2024 | ₹-718 Cr | Negative | |
| Mar2023 | ₹-1,521 Cr | Negative | |
| Mar2022 | ₹-762 Cr | Negative | |
| Mar2021 | ₹-840 Cr | - | |
Compare Net Current Assets of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹32,716.1 Cr | 4.8% | 25.7% | 11.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,104.0 Cr | 3.5% | -1.5% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,119.0 Cr | 1.1% | -1.1% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,871.0 Cr | -0.2% | -0.3% | 35% | Stock Analytics | |
| CIPLA | ₹114,334.0 Cr | 3.1% | 1% | -11.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,761.0 Cr | 1.1% | -2.1% | -5.6% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | 4.8% |
25.7% |
11.5% |
| SENSEX | 1.1% |
2.4% |
-5% |
You may also like the below Video Courses